TITLE

Whole-body FDG-PET screening detected indolent cancers when used with other tests

PUB. DATE
April 2009
SOURCE
Hem/Onc Today;4/10/2009, Vol. 10 Issue 7, p26
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article discusses a study on the use of whole-body Fludeoxyglucose-positron emission tomography (FDG-PET) screening in detecting early stage cancers.
ACCESSION #
37292870

 

Related Articles

  • Monitoring response to therapy in cancer using [[sup 18] F]-2-fluoro-2-deoxy-d-glucose and positron emission tomography: an overview of different analytical methods. Hoekstra, C. J.; Paglianiti, I.; Hoekstra, O. S.; Smit, E. F.; Postmus, P. E.; Teule, G. J. J.; Lammertsma, A. A. // European Journal of Nuclear Medicine;2000, Vol. 27 Issue 6, p731 

    Abstract. [[sup 18]F]-2-fluoro-2-deoxy-o-glucose positron emission tomography (FDG PET) is considered a valuable tool in the diagnosis and staging of cancer. In addition, it seems promising as a technique to monitor response to therapy. Progress is hampered, however, by the fact that various...

  • [sup 11] C-metomidate PET imaging of adrenocortical cancer. Khan, Tanweera S.; Sundin, Anders; Juhlin, Claes; Långström, Bengt; Bergström, Mats; Eriksson, Barbro // European Journal of Nuclear Medicine & Molecular Imaging;2003, Vol. 30 Issue 3, p403 

    The diagnostic potential of positron emission tomography (PET) with carbon-11 metomidate in patients with adrenocortical cancer (ACC) was evaluated. Thirteen PET examinations were performed in 11 patients with CT-detected primary tumours or recurrence and/or metastases from a previously...

  • Whole-body PET with FDG for the diagnosis of recurrent gastric cancer. De Potter, T.; Flamen, P.; Van Cutsem, E.; Penninckx, F.; Filez, L.; Bormans, G.; Maes, A.; Mortelmans, L. // European Journal of Nuclear Medicine & Molecular Imaging;2002, Vol. 29 Issue 4, p525 

    This retrospective study was designed to assess the accuracy of fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) in diagnosing recurrence of gastric cancer. Thirty-three patients who had received surgical treatment for gastric cancer with curative intent and who had...

  • Evaluation of (pre-)malignant colonic abnormalities: endoscopic validation of FDG-PET findings. Drenth, Joost H.; Nagengast, Fokko M.; Oyen, Wim G. // European Journal of Nuclear Medicine;2001, Vol. 28 Issue 12, p1766 

    The diagnostic accuracy of 2-[[sup 18]F]-fluoro-2deoxy-D-glucose positron emission tomography (FDGPET) for the detection of (pre-)malignant lesions of the colon was compared with that of endoscopy. We selected a cohort of 39 patients [13 females and 26 males; mean age 62.3 years standard...

  • The impact of FDG-PET on the management algorithm for recurrent colorectal cancer. Arulampalam, Tan; Costa, Durval; Visvikis, Dimitris; Boulos, Paul; Taylor, Irving; Ell, Peter // European Journal of Nuclear Medicine;2001, Vol. 28 Issue 12, p1758 

    Positron emission tomography (PET) has been successfully used to image colorectal cancer (CRC). This study evaluated the accuracy of 2-[[sup 18]F]-fluoro-2-deoxy-Dglucose (FDG) PET for the detection and staging of recurrent CRC and the consequent impact on clinical management. Forty-two patients...

  • Potential impact of [[sup 18]F]3'-deoxy-3'-fluorothymidine versus [[sup 18]F]fluoro-2-deoxy-d-glucose in positron emission tomography for colorectal cancer. Francis, D.L.; Visvikis, D.; Costa, D.C.; Arulampalam, T.H.A.; Townsend, C.; Luthra, S.K.; Taylor, I.; Ell, P.J. // European Journal of Nuclear Medicine & Molecular Imaging;2003, Vol. 30 Issue 7, p988 

    Fluorine-18 labelled fluoro-2-deoxy-d-glucose ([sup 18]FDG) positron emission tomography (PET) imaging demonstrates the increased glucose consumption of malignant cells, but problems with specificity have led to the development of new PET tracers. [[sup 18]F]3'-deoxy-3'-fluorothymidine ([sup...

  • Histopathologic correlates of degree of F-18 fluorodeoxyglucose uptake on PET in breast cancers. Talwar, Sumit; Ghesani, Munir // Hem/Onc Today;9/10/2010, Vol. 11 Issue 17, p15 

    The article discusses the diagnostic use of positron emission tomography to confirm a breast cancer diagnosis in a 68-year-old postmenopausal woman.

  • Abstracts. Smith, Jeanette M.; Cole, Thomas B. // JAMA: Journal of the American Medical Association;10/25/95, Vol. 274 Issue 16, p1254g 

    Presents an abstract of the research `Detection of Primary and Recurrent Lung Cancer by Means of F-18 Fluorodeoxyglucose Positron Emission Tomography (FDG PET),' by Francis G. Duhaylongsod et al published in a 1995 issue of the `Journal of Thoracic & Cardiovascular Surgery.'

  • COMMENT & RESPONSE. Moulton, Carol-Anne; Gulenchyn, Karen; Levine, Mark N. // JAMA: Journal of the American Medical Association;9/24/2014, Vol. 312 Issue 12, p1256 

    A response is presented from the authors of the article "Effect of PET before liver resection on surgical management for colorectal adenocarcinoma metastases: a randomized clinical trial" in the May 14, 2014 issue.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics